Evidence map›Paper›PMID 36832200›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Accuracy of Dose-Saving Artificial-Intelligence-Based 3D Angiography (3DA) for Grading of Intracranial Artery Stenoses: Preliminary Findings.

Stefan Lang, Philip Hoelter, Manuel Alexander Schmidt, Anne Mrochen, Joji Kuramatsu, Christian Kaethner, Philipp Roser, Markus Kowarschik, Arnd Doerfler

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefan LangDepartment of Neuroradiology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.
Philip HoelterDepartment of Neuroradiology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.ORCID 0000-0001-9768-9630
Manuel Alexander SchmidtDepartment of Neuroradiology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.ORCID 0000-0002-8560-2582
Anne MrochenDepartment of Neurology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.
Joji KuramatsuDepartment of Neurology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.ORCID 0000-0002-7630-7880
Christian KaethnerSiemens Healthcare GmbH, Advanced Therapies, Innovation, Siemensstraße 1, 91301 Forchheim, Germany.
Philipp RoserSiemens Healthcare GmbH, Advanced Therapies, Innovation, Siemensstraße 1, 91301 Forchheim, Germany.
Markus KowarschikSiemens Healthcare GmbH, Advanced Therapies, Innovation, Siemensstraße 1, 91301 Forchheim, Germany.ORCID 0000-0001-9962-3870
Arnd DoerflerDepartment of Neuroradiology, University Hospital of Erlangen-Nuremberg, 91054 Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeBased on artificial intelligence (AI), 3D angiography (3DA) is a novel postprocessing algorithm for "DSA-like" 3D imaging of cerebral vasculature. Because 3DA requires neither mask runs nor digital subtraction as the current standard 3D-DSA does, it has the potential to cut the patient dose by 50%. The object was to evaluate 3DA's diagnostic value for visualization of intracranial artery stenoses (IAS) compared to 3D-DSA. MATERIALS AND

methods3D-DSA datasets of IAS (n

resultsIn total, 20 angiographic 3D volumes (n

conclusionsThe AI-based 3DA is a resilient algorithm for the visualization of IAS and shows comparable results to 3D-DSA. Hence, 3DA is a promising new method that allows a considerable patient-dose reduction, and its clinical implementation would be highly desirable.

Indexed as

3D angiographyartificial intelligencedeep learningdose reductionflat-detector computed tomography (FD-CT)innovative postprocessingintracranial artery stenosis

Identifiers

PMID36832200
PMCPMC9954830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.